What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.16%Below 5Y avg (0.41%)
Annual Rate
CNY 0.05Paid annual
Payout Ratio
9.6%Sustainable
Last Ex-Dividend
Jun 11, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.93BCNY
1.48B · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
58.33x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
2.30BCNY
343.66M · vs all stocks (USD)
Updated Sep 20, 2026
Profit Margin
7.29%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Beta
0.6620x
vs all stocks
Updated Sep 20, 2026
52-Week Change
-52.08%
vs all stocks
Updated Sep 20, 2026
Market Capitalization
9.93BCNY
1.48B · vs all stocks (USD)
Updated Sep 20, 2026
Enterprise Value
10.54BCNY
1.57B · vs all stocks (USD)
Updated Sep 20, 2026
Trailing P/E
58.33x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Forward P/E
21.98x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Sales (TTM)
4.31x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Price to Book (MRQ)
3.32x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to Revenue
4.58x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Enterprise to EBITDA
64.63x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 32.67×.Updated Sep 20, 2026
Gross Margin
40.73%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 34.07%.Updated Sep 20, 2026
Profit Margin
7.29%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Margin
10.00%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Assets (TTM)
0.51%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Return on Equity (TTM)
4.69%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Revenue (TTM)
2.30BCNY
343.66M · vs all stocks (USD)
Updated Sep 20, 2026
Revenue per Share (TTM)
7.15CNYUpdated Sep 20, 2026
Quarterly Revenue Growth
-2.90%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Gross Profit (TTM)
784.74MCNY
117.10M · vs all stocks (USD)
Updated Sep 20, 2026
EBITDA (TTM)
322.71MCNY
48.16M · vs all stocks (USD)
Updated Sep 20, 2026
Net Income (TTM)
167.79MCNY
25.04M · vs all stocks (USD)
Updated Sep 20, 2026
Quarterly Earnings Growth (YoY)
2.80%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Operating Cash Flow (TTM)
87.69MCNY
13.09M · vs all stocks (USD)
Updated Sep 20, 2026
Levered Free Cash Flow (TTM)
-327.70MCNY
-48.90M · vs all stocks (USD)
Updated Sep 20, 2026
Trailing Annual Dividend Rate
0.0500CNYUpdated Sep 20, 2026
Trailing Annual Dividend Yield
0.16%
vs all stocks
Updated Sep 20, 2026
5-Year Average Dividend Yield
0.41%
vs all stocks
Updated Sep 20, 2026
Payout Ratio
9.62%
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Minority Interest (Equity)
129.23MCNYFY2025 · Dec 31, 2025
Revenue
2.41BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
1.66BCNYFY2025 · Dec 31, 2025
Gross Profit
755.43MCNYFY2025 · Dec 31, 2025
Operating Income
208.23MCNY
31.07M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
202.29MCNYFY2025 · Dec 31, 2025
Income Tax Expense
50.67MCNYFY2025 · Dec 31, 2025
Net Income
151.62MCNYFY2025 · Dec 31, 2025
EBIT
227.99MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
467.60MCNYFY2025 · Dec 31, 2025
Research & Development
234.87MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
158.27MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
23.73MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.83MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
25.70MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.4900CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.4900CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
324.11MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
324.11MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
151.62MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
7.20MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-160.19MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-363.88MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
594.23MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
151.62MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
41.04MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-261.68MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-91.17MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-203.69MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-22.64MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-270.16MCNYFY2025 · Dec 31, 2025
Sale of Investments
234.71MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-12.52MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-274.30MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
607.27MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-492.08MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-37.49MCNYFY2025 · Dec 31, 2025
Other Financing Charges
15.47MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
93.17MCNYFY2025 · Dec 31, 2025
Shares Outstanding
327.45MSharesUpdated Sep 20, 2026
Float Shares
249.77MSharesUpdated Sep 20, 2026
% Held by Insiders
22.57%
vs all stocks
Updated Sep 20, 2026
% Held by Institutions
5.82%
vs all stocks
Updated Sep 20, 2026
Total Cash (MRQ)
505.76MCNY
75.47M · vs all stocks (USD)
Updated Sep 20, 2026
Total Cash per Share (MRQ)
1.54CNYUpdated Sep 20, 2026
Total Debt (MRQ)
1.00BCNY
149.27M · vs all stocks (USD)
Updated Sep 20, 2026
Total Debt to Equity (MRQ)
0.3215x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Current Ratio (MRQ)
1.88x
vs Scientific & Technical Instruments peers
Updated Sep 20, 2026
Book Value per Share (MRQ)
9.14CNYUpdated Sep 20, 2026
Total Assets
5.16BCNY
770.32M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.98BCNYFY2025 · Dec 31, 2025
Total Liabilities
2.10BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
2.19BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
395.80MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.71BCNYFY2025 · Dec 31, 2025
Cash
599.34MCNYFY2025 · Dec 31, 2025
Cash Equivalents
23.62MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
622.96MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
15.00MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.45BCNYFY2025 · Dec 31, 2025
Inventory
562.29MCNYFY2025 · Dec 31, 2025
Accounts Payable
687.14MCNYFY2025 · Dec 31, 2025
Short-term Debt
740.02MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
33.45MCNYFY2025 · Dec 31, 2025
Long-term Debt
270.00MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
3.53MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
327.45MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.26BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.06BCNY
456.58M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
28.21CNYUpdated Sep 20, 2026
52-Week High
67.88CNYUpdated Sep 20, 2026
52-Week Change
-52.08%
vs all stocks
Updated Sep 20, 2026
Beta
0.6620x
vs all stocks
Updated Sep 20, 2026
50-Day MA
32.28CNYUpdated Sep 20, 2026
200-Day MA
43.85CNYUpdated Sep 20, 2026
Avg 10-Day Volume
7.79MSharesUpdated Sep 20, 2026
Avg 30-Day Volume
8.08MSharesUpdated Sep 20, 2026
Diluted EPS (TTM)
0.5200CNYUpdated Sep 20, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable